can you switch to tirzepatide from semaglutide Switching Tirzepatide: Is It a Good Idea? Transitioning Treatments: What to Expect

not recommended for use with DPP-4 inhibitors Common side effects : Gastrointestinal symptoms (nausea, vomiting, diarrhea) that typically diminish with continued use and proper dose titration Referral to endocrinology or obesity medicine specialists is appropriate for complex cases, including patients with multiple failed therapies, significant comorbidities, or those requiring comprehensive weight management programs

Weeks 1 to 4: Reduce from 2.4 mg to 1.7 mg weekly

During the early stages of GLP-1 therapy, its common to experience gastrointestinal (GI) side effects such as nausea, bloating, constipation, or early fullness

Hunger and satiety signals travel between your digestive system and brain via both the vagus nerve and circulating hormones

What is the Endothelium